Literature DB >> 1031368

Studies of chemical and biological properties of 99mTc-DMS (dimercaptosuccinic acid)--renal imaging agent.

N M Vanlić-Razumenić, D A Gorkić.   

Abstract

Studies of the chemistry of preparation of tin chelate 2.3-dimercaptosuccinic acid (DMS) complexed with 99mTc with respect to its biological properties have been made. We have varied molar ratio of reactants (DMS:Sn/II/), concentration of Sn-DMS chelate and pH of 99mTc-DMS injection solution and examined their influence on biodistribution. Biodynamics of labeled solution at time intervals of from 0.5 to 4 h have also been measured. Animal experiments were carried out on mice and rats. Radiochemical purity was checked by paper chromatography, thin-layer chromatography, and gel-filtration through Bio-Gel P-2. A sterile, pyrogen-free lyophilized "kit" for labeling, stable for 6 months, was made on the basis of achieved results. The results of its clinical application are also reported.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1031368     DOI: 10.1007/BF00252169

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Clinical experience with 99mTc-DMSA (dimercaptosuccinic acid), a new renal-imaging agent.

Authors:  H Handmaker; B W Young; J M Lowenstein
Journal:  J Nucl Med       Date:  1975-01       Impact factor: 10.057

2.  Chromatographic quality control of 99mTc-labeled compounds.

Authors:  M W Billinghurst
Journal:  J Nucl Med       Date:  1973-11       Impact factor: 10.057

3.  Letter: Gel chromatography as an analytical tool for 99mTc radiopharmaceuticals.

Authors:  M W Billinghurst; R F Palser
Journal:  J Nucl Med       Date:  1974-08       Impact factor: 10.057

4.  A 99mTc-chelate substitute for organoradiomercurial renal agents.

Authors:  T H Lin; A Khentigan; H S Winchell
Journal:  J Nucl Med       Date:  1974-01       Impact factor: 10.057

5.  Renal cortical imaging in 35 patients: superior quality with 99mTc-DMSA.

Authors:  D Enlander; P M Weber; L V dos Remedios
Journal:  J Nucl Med       Date:  1974-09       Impact factor: 10.057

6.  A possible artifact in gel chromatography of some 99m Tc-chelates.

Authors:  P E Valk; C A Dilts; J McRae
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

7.  Analytical pitfalls with 99m Tc-labeled compounds.

Authors:  W C Eckelman; P Richards
Journal:  J Nucl Med       Date:  1972-03       Impact factor: 10.057

8.  Chelating therapy with Na-DMS in occupational lead and mercury intoxications.

Authors:  S C Wang; K S Ting; C C Wu
Journal:  Chin Med J       Date:  1965-07

9.  Comparison of 99mTc complexes for renal imaging.

Authors:  R W Arnold; G Subramanian; J G McAfee; R J Blair; F D Thomas
Journal:  J Nucl Med       Date:  1975-05       Impact factor: 10.057

10.  Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.

Authors:  P Hambright; J McRae; P E Valk; A J Bearden; B A Shipley
Journal:  J Nucl Med       Date:  1975-06       Impact factor: 10.057

  10 in total
  3 in total

1.  Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. I. Subcellular localization of 99mTc-DMS complex in the rat kidney in vivo.

Authors:  N Vanlić-Razumenić; J Petrović
Journal:  Eur J Nucl Med       Date:  1981-04

2.  99mTc-methyl-CCNU for the static imaging of kidneys.

Authors:  M T Ercan; I S Or; C F Bekdik; T Sarizi; A Yazicioglu
Journal:  Eur J Nucl Med       Date:  1980-04

3.  A kinetic model for 99mTc-DMSA in the rat.

Authors:  D C Maneval; D Z D'Argenio; W Wolf
Journal:  Eur J Nucl Med       Date:  1990
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.